Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.
- NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_assertion description "[Our identification of XRCC2 as a breast cancer susceptibility gene thus increases the proportion of breast cancers that are associated with homologous recombination-DNA-repair dysfunction and Fanconi anemia and could therefore benefit from specific targeted treatments such as PARP (poly ADP ribose polymerase) inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.
- NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_assertion evidence source_evidence_literature NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.
- NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_assertion SIO_000772 22464251 NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.
- NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_assertion wasDerivedFrom befree-20150227 NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.
- NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_assertion wasGeneratedBy ECO_0000203 NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.
- befree-20150227 importedOn "2015-02-27" NP224989.RARYe-WpMLK19WxatoM9jqjlsWcS8hF-fYtVxTC4aw-po130_provenance.